Latest news with #bloodclots
Health Line
28-05-2025
- General
- Health Line
Ulcerative Colitis (UC) and Blood Clots: Can Anticoagulant Medications Help?
UC may increase your likelihood of forming a blood clot. Talk with your doctor about the potential risks and benefits of anticoagulant medications. Some people with ulcerative colitis experience hypercoagulability, which means their risk for blood clots is increased. Learn more about the connection between these two conditions and whether anticoagulant medications are a beneficial treatment for this possible effect. Does ulcerative colitis cause bleeding or blood clots? People with ulcerative colitis are three times more likely to experience a thromboembolism (blood clot) compared with those who don't have ulcerative colitis. It's important to remember that blood clotting is your body's natural response to bleeding. You need your blood to clot so you won't bleed excessively. It's important to keep a balance of blood clotting factors so they won't cause you to form a blood clot when you don't need to. Symptoms of blood clots with UC Doctors first connected an increased risk of blood clots with ulcerative colitis when they observed young people experiencing blood clots at a younger-than-expected age. If you have ulcerative colitis, it's important to be aware of your increased clotting risk, but also to know the incidence of a clot is about 1% to 8% of all people with ulcerative colitis. Blood clots can cause a venous thromboembolism, which is a clot that usually forms in a deep vein of your leg. Doctors call this deep vein thrombosis (DVT). Symptoms of a DVT include: discoloration of your leg or red-appearing streaks leg pain/tenderness leg swelling part of your leg feels warm to the touch However, clots can also travel from your legs to your lungs, which doctors call a pulmonary embolism (PE), or blood clot in the lungs. Symptoms of a PE include: chest pain that worsens with breathing feeling dizzy losing consciousness rapid heart rate sudden shortness of breath very fast breathing If you experience these or other clot-related symptoms, get emergency medical attention. What is the safest medication for ulcerative colitis with bleeding? Clotting requires a multi-step process. Anticoagulant medications target different steps in this process to prevent clots from forming when they aren't supposed to. However, anticoagulant medications may increase your risk of more severe rectal bleeding when you have an ulcerative colitis flare-up. For this reason, doctors won't usually prescribe anticoagulant medications to you unless you're in an active flare-up (and usually in the hospital), after a surgery, or have already had a blood clot in the past. Each of these instances increases your risk of blood clotting. The most common recommendation if you are in the hospital with active IBD is to go for walks. A number of anticoagulant medications are available, and which one your doctor prescribes may depend upon how long you're going to take it, your overall health, and even what medications your insurance will cover to help keep your costs low. There's no one medication that's the 'gold standard' of anticoagulation treatment for a patient. Examples of anticoagulation medications include: If a doctor does prescribe anticoagulants to you, you can ask how the medication works and why it may be the best option for you. Living with ulcerative colitis Getting an ulcerative colitis diagnosis can be understandably life changing. It's important to get help and support so you can manage your condition and live well. Some resources include: American College of Gastroenterology Crohn's & Colitis Foundation Connecting to Cure Crohn's & Colitis IDB Support Foundation Bezzy IBD Community Healthline also has a listing of numerous resources, social media pages, and blogs that can help.
Yahoo
18-05-2025
- Health
- Yahoo
AI breakthrough allows doctors to 'see' dangerous blood clots forming
AI technology could be used to detect potentially deadly blood clots before they strike. That's according to scientists at the University of Tokyo, who say they have created a non-invasive way to observe clotting activity in blood as it occurs. The new artificial intelligence tool uses a powerful microscope to monitor platelets in real time, the researchers shared in a press release from the university. What Is Artificial Intelligence (Ai)? Platelets, which are tiny blood cells that help form clots to stop bleeding, play a "crucial role" in heart disease, particularly coronary artery disease, according to Dr. Kazutoshi Hirose, lead author of the study. If the platelet count is too high, it can increase the risk of blood clots. Read On The Fox News App To prevent dangerous clots, patients with coronary artery disease are usually treated with anti-platelet drugs. "However, it's still challenging to accurately evaluate how well these drugs are working in each individual, which makes monitoring platelet activity an important goal for both doctors and researchers," Hirose said in the press release. Traditional methods of monitoring platelet activity often rely on indirect measurements or invasive procedures. With the AI tool, a high-powered microscope works like a "super-high-speed camera that takes sharp pictures of blood cells in flow," said Yuqi Zhou, assistant professor of chemistry at the University of Tokyo, in the release. Artificial Intelligence Transforms Patient Care And Reduces Burnout, Physician Says "Just like traffic cameras capture every car on the road, our microscope captures thousands of images of blood cells in motion every second," he said. "We then use artificial intelligence to analyze those images." The AI can distinguish between a single platelet ("like one car"), a clump of platelets ("like a traffic jam"), or even a white blood cell tagging along ("like a police car caught in the jam"), Zhou described. "This technology stands out because it allows doctors to directly observe platelets in the bloodstream and measure how they interact and form clumps in real time," said Keisuke Goda, a professor at The University of Tokyo's chemistry department, in the release. "Our studies have shown it to be highly effective in patients with coronary artery disease, the most common cause of heart attacks and one of the leading causes of death in the U.S. and the world," he added. When the researchers tested the technique on over 200 patients, they found that people with more serious heart problems had more clumping in their blood. A blood sample taken from a patient's arm and tested with the tool resulted in nearly the same results as blood taken directly from the heart's arteries, they noted. Harvey Castro, a Texas-based emergency physician and AI expert, described the implications as significant for patient care. "Today, we rely on indirect lab markers or invasive cath-lab blood draws to judge clot risk," Castro, who was not involved in the study, told Fox News Digital. "This technology turns an ordinary venous draw into live telemetry of platelet behavior, giving answers in seconds rather than hours." These advancements have the potential to change the standard of care for patients with coronary heart disease, according to the researchers. Click Here To Sign Up For Our Health Newsletter "Typically, if doctors want to understand what's happening in the arteries, especially the coronary arteries, they need to do invasive procedures, like inserting a catheter through the wrist or groin to collect blood," said Hirose. "What we found is that just taking a regular blood sample from a vein in the arm can still provide meaningful information about platelet activity in the arteries." For more Health articles, visit Goda agreed that the tool could enable safer, more personalized treatments for heart disease patients. "Right now, doctors often give blood-thinning drugs and hope they are working," he said. "With this method, they could actually see if the treatment is working in each patient." Castro cautioned that the technology is not yet ready for widespread use. "The microscope is cutting-edge research gear, not yet a bedside device," he told Fox News Digital. "We need miniaturization and cost drops before every ER can use it." Looking ahead, after further research, Castro envisions that this innovation could change point-of-care decision-making for patients. "Five years from now, I can imagine a point-of-care analyzer that lets me adjust antiplatelet drugs and how I titrate oxygen quickly and safely for the patient in front of me," he article source: AI breakthrough allows doctors to 'see' dangerous blood clots forming
Fox News
18-05-2025
- Health
- Fox News
AI breakthrough allows doctors to 'see' dangerous blood clots forming
AI technology could be used to detect potentially deadly blood clots before they strike. That's according to scientists at the University of Tokyo, who say they have created a non-invasive way to observe clotting activity in blood as it occurs. The new artificial intelligence tool uses a powerful microscope to monitor platelets in real time, the researchers shared in a press release from the university. Platelets, which are tiny blood cells that help form clots to stop bleeding, play a "crucial role" in heart disease, particularly coronary artery disease, according to Dr. Kazutoshi Hirose, lead author of the study. If the platelet count is too high, it can increase the risk of blood clots. To prevent dangerous clots, patients with coronary artery disease are usually treated with anti-platelet drugs. "However, it's still challenging to accurately evaluate how well these drugs are working in each individual, which makes monitoring platelet activity an important goal for both doctors and researchers," Hirose said in the press release. Traditional methods of monitoring platelet activity often rely on indirect measurements or invasive procedures. With the AI tool, a high-powered microscope works like a "super-high-speed camera that takes sharp pictures of blood cells in flow," said Yuqi Zhou, assistant professor of chemistry at the University of Tokyo, in the release. "Just like traffic cameras capture every car on the road, our microscope captures thousands of images of blood cells in motion every second," he said. "We then use artificial intelligence to analyze those images." The AI can distinguish between a single platelet ("like one car"), a clump of platelets ("like a traffic jam"), or even a white blood cell tagging along ("like a police car caught in the jam"), Zhou described. "Right now, doctors often give blood-thinning drugs and hope they are working. With this method, they could actually see if the treatment is working." "This technology stands out because it allows doctors to directly observe platelets in the bloodstream and measure how they interact and form clumps in real time," said Keisuke Goda, a professor at The University of Tokyo's chemistry department, in the release. "Our studies have shown it to be highly effective in patients with coronary artery disease, the most common cause of heart attacks and one of the leading causes of death in the U.S. and the world," he added. When the researchers tested the technique on over 200 patients, they found that people with more serious heart problems had more clumping in their blood. A blood sample taken from a patient's arm and tested with the tool resulted in nearly the same results as blood taken directly from the heart's arteries, they noted. Harvey Castro, a Texas-based emergency physician and AI expert, described the implications as significant for patient care. "Today, we rely on indirect lab markers or invasive cath-lab blood draws to judge clot risk," Castro, who was not involved in the study, told Fox News Digital. "This technology turns an ordinary venous draw into live telemetry of platelet behavior, giving answers in seconds rather than hours." These advancements have the potential to change the standard of care for patients with coronary heart disease, according to the researchers. "Typically, if doctors want to understand what's happening in the arteries, especially the coronary arteries, they need to do invasive procedures, like inserting a catheter through the wrist or groin to collect blood," said Hirose. "What we found is that just taking a regular blood sample from a vein in the arm can still provide meaningful information about platelet activity in the arteries." For more Health articles, visit Goda agreed that the tool could enable safer, more personalized treatments for heart disease patients. "Right now, doctors often give blood-thinning drugs and hope they are working," he said. "With this method, they could actually see if the treatment is working in each patient." Castro cautioned that the technology is not yet ready for widespread use. "The microscope is cutting-edge research gear, not yet a bedside device," he told Fox News Digital. "We need miniaturization and cost drops before every ER can use it." Looking ahead, after further research, Castro envisions that this innovation could change point-of-care decision-making for patients. "Five years from now, I can imagine a point-of-care analyzer that lets me adjust antiplatelet drugs and how I titrate oxygen quickly and safely for the patient in front of me," he said.
CBS News
16-05-2025
- Sport
- CBS News
Patriots' Christian Barmore cleared for 2025 season after blood clot scares
Patriots defensive tackle Christian Barmore had a roller coaster of a 2024 season as he battle recurring symptoms from blood clots. On Thursday, the 25-year-old told reporters those battles are behind him. Barmore took the podium at Gillette Stadium on Thursday and told reporters he's been cleared for full participation in football activities. He anticipates being on the field when New England kicks off the 2025 NFL season against the Las Vegas Raiders on Sept. 7. "Yeah. That's the goal," said an upbeat Barmore. "I just have to keep following the medical team. But everything is looking really good." Barmore sounded and looked much more like his usual self, and his confidence is back after a scary 2024. "Feeling better, keep getting better, feeling good, more confidence in myself. Back with my breathing. So I'm just feeling really good," he said. "I'm talking my smack, yeah. All that." Barmore was primed for a big 2024 season after he signed a $92 million extension with the Patriots last April, but he was diagnosed with blood clots in training camp and was placed on the Non-Football Injury list. He was cleared to return in November and played in four games, but the blood clot symptoms returned and Barmore landed back on the NFI list. "It was really hard, man. That was one of the hardest times for me," Barmore said of his November scare. "I wanted to be out there. I wanted to support my brothers." Barmore said he doesn't have any concerns about those symptoms resurfacing going forward. Christian Barmore's return to Patriots defense Having a behemoth like Barmore back in the middle of the New England defensive line will be huge for the Patriots. His return, plus the addition of free-agent Milton Williams, should greatly improve the Patriots' rush defense, which was the 23rd-worst in the NFL in 2024. Barmore was a monster in 2023, when he led the team with 8.5 sacks and was second with 13 tackles for loss amid his breakout season. It was easy to understand why the Patriots gave him such a big extension and see him as a key cog on the defensive front. Mix Barmore's return with the addition of Williams and head coach Mike Vrabel, and the New England defense should be a stout unit up front. Barmore hopes his medical scare from last season is completely in the past, but it will continue to motivate him going forward. "Last year really hit me – use that as motivation and anger because it's making me work even harder," he said. "That situation was like I could have lost a lot and literally all the work I put in could have been taken away and I've been really hurt. I can never take things for granted and just keep on working even harder and keep doing what God planned."
Fox News
15-05-2025
- Health
- Fox News
Patriots' Christian Barmore set to return to field after suffering from blood clots
New England Patriots defensive tackle Christian Barmore was hit with a huge blow last year when he was diagnosed with blood clots. His 2024 season was cut short, but the 2021 second-round pick received great news on Thursday. Barmore was cleared for football activity, paving the way for a return to the gridiron later this year. Barmore will be a full participant in voluntary organized team activities (OTAs) next week. "Yeah. That's the goal. I just have to keep following the medical team, but everything is looking really well," Barmore said. Barmore was initially diagnosed with the clots in July, but he was able to get back on the field in November. However, he only managed to play in just four games before hitting the non-football illness list. "It was one of the hardest times. I felt like I did everything in my power, wanting to come back," Barmore said, via ESPN. "I don't want to ever be in that situation again, or anybody in the world to go through that. That stuff was no joke. It was a hard challenge." "Feeling good, more confidence in myself, back to my breathing. Talking my smack, yeah. All of that," he added. "Really blessed." He had a breakout third season with the Patriots in 2023, collecting a career-high 8.5 sacks and 64 combined tackles over 17 games. It's what led the Patriots to sign him to a four-year extension worth a maximum $92 million, including $41.8 million guaranteed at signing before he began the final year on his rookie deal. The team has dealt with a player getting blood clots in the past. Center David Andrews, a long-time veteran with the organization, was diagnosed with clots in his lungs in 2019. Andrews eventually returned to play in 2020. Follow Fox News Digital's sports coverage on X, and subscribe to the Fox News Sports Huddle newsletter.
